Cite
HARVARD Citation
Matthews Hew, T. et al. (2019). PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms. Journal of investigative medicine high impact case reports. p. . [Online].